Abstract
A Phase 2 Study of Actinium-225 (225Ac)-Lintuzumab in Older Patients with Previously Untreated Acute Myeloid Leukemia (AML) Unfit for Intensive Chemotherapy
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have